European Archives - Page 436 of 899 - European Medical Journal

Talking to Mircea Cubillos

Mircea Cubillos, Vice President Hematology EMEA, Commercial Strategy Lead, Janssen, discusses his lengthy career at Janssen, progression in oncology during COVID-19, and cultivating healthy habits during lockdown.

Stool Microbiome of Patients Indicate Cirrhosis Risk

MICROBIOTA from stool samples of patients with nonalcoholic fatty liver disease (NAFLD) may be used to predict which individuals are at greatest risk…

Higher Doses of Protein Pump Inhibitors May Increase COVID-19 Risk

PROTEIN-PUMP inhibitors (PPI) taken by those with indigestion may increase an individual’s risk of developing COVID-19.

Interview: Professor Michael Barnes

I became interested whilst working in multiple sclerosis clinics roughly 20 years ago. Some of my patients came to the clinic and told me that they…

Moving from The Periphery to The Core of The Matter – Where Does Opicapone▼ Fit in Parkinson’s Disease?

Presented here are highlights of a virtual satellite symposium from the European Academy of Neurology (EAN) 2020 Virtual Congress…

An Evaluation of the Studies on the Therapeutic Effects of Yoga in People with Dementia

The global population is ageing, and the prevalence of dementia is increasing. Current conventional drug therapy lacks efficacy; therefore…

Review of the European Academy of Neurology (EAN) Virtual Congress 2020

This year, the 6th Annual Meeting of the European Academy of Neurology (EAN) took place virtually as a result of the ongoing COVID-19 pandemic…

Α Multicenter Retrospective Study Evaluating Brivaracetam in the Treatment of Epilepsies in Clinical Practice

Brivaracetam (BRV) is the latest approved antiepileptic drug and acts as a synaptic vesicle protein 2A ligand…

Editor's Pick: Current Paradigms to Explore the Gut Microbiota Linkage to Neurological Disorders

The human body harbours a diverse community of symbiotic, commensal, and pathogenic micro-organisms including bacteria, viruses, and fungi…

EMJ Neurology 8.1 2020

We are proud to share with you an impressive collection of new and interesting research…